Semaglutide vs Dulaglutide
Two once-weekly GLP-1 agonists compared.
| Attribute | Semaglutide GLP-1 receptor agonist | Dulaglutide Trulicity |
|---|---|---|
| Category | Weight Loss & Metabolism | Weight Loss & Metabolism |
| Best known for | Weight loss and blood sugar research | Long-acting GLP-1 agonist research |
| In plain English | Semaglutide mimics the hormone your gut releases when you eat. The brain reads it as 'we're full,' appetite drops, and stomach emptying slows down. | Same idea as semaglutide — long-acting GLP-1 — with a different molecular backbone. |
| How it works | Activates the GLP-1 receptor in the pancreas, brain, and gut — increasing insulin secretion, slowing gastric emptying, and reducing appetite through hypothalamic signaling. | Activates GLP-1 receptors to enhance glucose-dependent insulin secretion, suppress glucagon, and slow gastric emptying. |
| Researchers study | Glycemic control, weight reduction, cardiovascular outcomes, and emerging research in addiction and neuroinflammation. | Type 2 diabetes, cardiovascular risk reduction, and weight management. |
| Internet discussion | The internet talks about semaglutide constantly — 'Ozempic face,' food noise reduction, alcohol cravings dropping, and dose-titration questions. | Discussed alongside semaglutide and tirzepatide on GLP-1 forums. |
Semaglutide
Weight loss and blood sugar research
Semaglutide mimics the hormone your gut releases when you eat. The brain reads it as 'we're full,' appetite drops, and stomach emptying slows down.
Activates the GLP-1 receptor in the pancreas, brain, and gut — increasing insulin secretion, slowing gastric emptying, and reducing appetite through hypothalamic signaling.
Glycemic control, weight reduction, cardiovascular outcomes, and emerging research in addiction and neuroinflammation.
The internet talks about semaglutide constantly — 'Ozempic face,' food noise reduction, alcohol cravings dropping, and dose-titration questions.
Semaglutide is the reference GLP-1 agonist — well-studied for blood sugar control and significant weight reduction.
Dulaglutide
Long-acting GLP-1 agonist research
Same idea as semaglutide — long-acting GLP-1 — with a different molecular backbone.
Activates GLP-1 receptors to enhance glucose-dependent insulin secretion, suppress glucagon, and slow gastric emptying.
Type 2 diabetes, cardiovascular risk reduction, and weight management.
Discussed alongside semaglutide and tirzepatide on GLP-1 forums.
Dulaglutide is a long-acting GLP-1 receptor agonist researched for glucose control and weight management.